Screening of DNA aptamer which binds to α-synuclein

Biotechnology Letters

Volumn 32, Issue 5, 2010, Pages 643-648

  Tsukakoshi, Kaori ^a   Harada, Ryuichi ^a   Sode, Koji ^a   Ikebukuro, Kazunori ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Synuclein; Alzheimer's disease; DNA aptamer; Lewy bodies; Parkinson's disease

Indexed keywords

ALZHEIMER'S DISEASE; APTAMERS; LEWY BODIES; PARKINSON'S DISEASE; SYNUCLEIN;

DNA; GENES;

DIAGNOSIS;

ALPHA SYNUCLEIN; APTAMER;

ARTICLE; DRUG SCREENING; GEL MOBILITY SHIFT ASSAY; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING;

ALPHA-SYNUCLEIN; APTAMERS, NUCLEOTIDE; DRUG EVALUATION, PRECLINICAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; PROTEIN BINDING;

EID: 77952240896     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-010-0200-5     Document Type: Article

References (17)

1. Ding TT, Lee SJ, Rochet JC, Lansbury PT Jr (2002) Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes. Biochemistry 41: 10209-10217.
2. El-Agnaf OM, Salem SA, Paleologou KE et al (2006) Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J 20: 419-425.
3. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818-822.
4. Huang Z, Pei W, Han Y, Jayaseelan S et al (2009) One RNA aptamer sequence, two structures: a collaborating pair that inhibits AMPA receptors. Nucleic Acids Res 37(12): 4022-4032.
5. Kobayashi M, Kim J, Kobayashi N et al (2006) Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein. Biochem Biophys Res Commun 349: 1139-1144.
6. Mathews DH, Sabina J, Zuker M et al (1999) Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol 288: 911-940.
7. Ogasawara D, Hasegawa H, Kaneko K et al (2007) Screening of DNA aptamer against mouse prion protein by competitive selection. Prion 1: 248-254.
8. Paleologou KE, Kragh CL, Mann DM et al (2009) Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. Brain 132: 1093-1101.
9. Proske D, Gilch S, Wopfner F et al (2002) Prion-protein-specific aptamer reduces PrPSc formation. Chembiochem 3: 717-725.
10. Rhie A, Kirby L, Sayer N et al (2003) Characterization of 2′-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. J Biol Chem 278: 39697-39705.
11. Takahashi T, Tada K, Mihara H (2009) RNA aptamers selected against amyloid beta-peptide (Abeta) inhibit the aggregation of Abeta. Mol Biosyst 5: 986-991.
12. Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510.
13. Weinreb PH, Zhen W, Poon AW et al (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35(43): 13709-13715.
14. Weiss S, Proske D, Neumann M et al (1997) RNA aptamers specifically interact with the prion protein PrP. J Virol 71: 8790-8797.
15. Ylera F, Lurz R, Erdmann VA, Furste JP (2002) Selection of RNA aptamers to the Alzheimer's disease amyloid peptide. Biochem Biophys Res Commun 290: 1583-1588.
16. Yoshida W, Sode K, Ikebukuro K (2006) Aptameric enzyme subunit for biosensing based on enzymatic activity measurement. Anal Chem 78: 3296-3303.
17. Yoshida W, Sode K, Ikebukuro K (2008) Label-free homogeneous detection of immunoglobulin E by an aptameric enzyme subunit. Biotechnol Lett 30(3): 421-425.